Media Healthcare Sector

Sonnet BioTherapeutics Holdings

Market Cap: US$4.0m

A biotechnology company, owns a platform for biologic medicines of single or bifunctional action.

Mosaic ImmunoEngineering

Market Cap: US$3.9m

A development-stage biotechnology company, focuses on advancing and commercialization of immunotherapies for the treatment of cancer.

XORTX Therapeutics

Market Cap: CA$5.5m

A late-stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat gout and progressive kidney disease.

Adherium

Market Cap: AU$6.1m

Develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, and North America.

ALR Technologies SG

Market Cap: US$3.9m

A data management company, provides diabetes care management solutions for human and animal health diabetes.

PainReform

Market Cap: US$3.8m

A clinical stage specialty pharmaceutical company, focuses on the reformulation of established therapeutics and provides an extended period of post-surgical pain relief in Israel.

GlucoTrack

Market Cap: US$3.8m

A medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States.

Galecto

Market Cap: US$3.8m

A clinical-stage biotechnology company, develops molecule therapeutics for the treatment of fibrosis, cancer, inflammation, and other related diseases.

bioAffinity Technologies

Market Cap: US$3.8m

Engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States.

Totally

Market Cap: UK£2.8m

Provides healthcare services in the United Kingdom and Ireland.

Mitesco

Market Cap: US$3.8m

Provides cloud computing, application hosting, and other data center related applications.

MYND Life Sciences

Market Cap: CA$5.2m

A life sciences-based neuro-pharmaceutical drug development company, advances medicines based on neuro-anti-inflammatory substances for depressive disorders through science and clinical trials in Canada and the United States.

Lixte Biotechnology Holdings

Market Cap: US$3.7m

A clinical-stage biopharmaceutical company, focuses on identifying targets for cancer drug development, and developing and commercializing cancer therapies.

Mustang Bio

Market Cap: US$3.7m

A clinical-stage biopharmaceutical company, focuses on translating cell therapies into cures for difficult-to-treat cancers and autoimmune diseases.

VivoSim Labs

Market Cap: US$3.7m

A biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease.

Uscom

Market Cap: AU$5.8m

Designs, develops, manufactures, and markets non-invasive cardiovascular and pulmonary medical devices in Australia, Asia, the Americas, and Europe.

Rua Bioscience

Market Cap: NZ$6.3m

Engages in the research, development, and manufacturing of pharmaceutical products in New Zealand and internationally.

60 Degrees Pharmaceuticals

Market Cap: US$3.6m

A specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States.

Verici Dx

Market Cap: UK£2.7m

Develops prognostic and diagnostic tests for kidney transplant patients.

BSF Enterprise

Market Cap: UK£2.7m

Develops and commercializes cutting-edge tissue-engineered solutions.

StageZero Life Sciences

Market Cap: CA$4.9m

A vertically integrated healthcare company, develops and commercializes proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications in North America and Western Europe.

CTT Pharmaceutical Holdings

Market Cap: US$3.6m

Engages in the development of oral drug delivery systems for pain management and treatment.

Premier Health of America

Market Cap: CA$5.0m

Engages in the provision of staffing and outsourced service solutions for healthcare needs in Canada.

FinCanna Capital

Market Cap: CA$5.0m

Does not have significant operations.

InMed Pharmaceuticals

Market Cap: US$3.6m

A clinical stage pharmaceutical company, develops a pipeline of prescription-based products in the United States.

HeartSciences

Market Cap: US$3.5m

A medical technology company, focuses on applying AI-based technology to an ECG to enhance its clinical utility.

Leveljump Healthcare

Market Cap: CA$4.8m

Provides radiology services.

Genetic Technologies

Market Cap: AU$5.7m

A molecular diagnostics company, engages in the provision of predictive genetic testing and risk assessment tools to help physicians manage people’s health in the America, Canada, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.

ProtoKinetix

Market Cap: US$3.4m

A research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs).

Kineta

Market Cap: US$3.4m

A clinical-stage biotechnology company, engages in developing immunotherapies that transform patients’ lives in the United States.

NovaBay Pharmaceuticals

Market Cap: US$3.4m

Does not have significant operations.

SciSparc

Market Cap: US$3.4m

A clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies.

InhaleRx

Market Cap: AU$5.3m

A biotechnology company, develops and sells registrable inhaled drug-device combinations in Australia.

Enzolytics

Market Cap: US$3.4m

Enzolytics Inc., a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases.

Ensysce Biosciences

Market Cap: US$3.3m

A clinical-stage pharmaceutical company, develops prescription drugs for severe pain relief in opioid misuse, abuse, and overdose in the United States.

Biodexa Pharmaceuticals

Market Cap: US$3.3m

A clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of familial adenomatous polyposis, non-muscle invasive bladder cancer, and Type 1 diabetes and rare/orphan cancers of the brain.